Sanford patented product receives FDA clearance
Contact:
John Schindler, CEO
Liquet Medical Inc.
(804) 690-9564 / j.schindler@liquetmedical.com
www.liquetmedical.com
Jon Berg
Sanford Health Media Relations
605-366-2432 / Jon.Berg@sanfordhealth.org
SIOUX FALLS, S.D. and CHARLOTTESVILLE, VA — Liquet Medical Inc., a pioneering medical device company committed to advancing patient care through innovative technologies, announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Versus™ Catheter, patented by Sanford Health and invented by Dr. Patrick Kelly during his employment as a Sanford physician.
This innovative medical device is set to enhance the treatment of pulmonary artery blood clots by offering real-time pulmonary artery pressure measurements, empowering clinicians to optimize treatment based on individual patient responses. This novel technology enables a new treatment category called “Hemodynamics-Led Thrombolysis (HLT).”
“The Versus™ Catheter will allow for a more data-centric approach to each individual patient suffering from blood clots in their lungs,” said Luke Wilkins, MD, Interventional Radiologist at UVA Health who will be working closely with the Versus™ Catheter. “Hemodynamic-led thrombolytic therapy is an opportunity to potentially improve patient outcomes, and we are looking forward to studying this device.”
Key Features and Benefits of the Versus™ Catheter:
- Real-Time Pulmonary Artery Pressure Monitoring: Provides physicians live data to assess patient hemodynamics before and during therapy to optimize treatment decisions.
- Dual-Tip Telescoping Catheter: Enables simultaneous treatment of both lungs with a single device, offering access site alternatives to the physician, and improving healthcare efficiency.
- Flexible Placement: Standard guidewire technique or flow-directed balloon placement.
“FDA 510(k) clearance is a significant milestone for Liquet Medical and enables the commercial release of the Versus™ Catheter to hospitals and clinics across the U.S.,” said John Schindler, CEO of Liquet Medical. “We believe this innovation has the potential to significantly improve patient outcomes, minimize risks, and reduce healthcare costs.”
Sanford’s investment in the patenting and development of this technology demonstrates our commitment to advancing health care. By investing in the ideas of frontline staff, Sanford Health is not only fostering a culture of innovation but also highlighting the crucial role of frontline innovation in transforming patient care.
About Liquet Medical
Liquet™ Medical is a forward-thinking medical device company focused on developing next-generation solutions for blood clots and other vascular conditions. Liquet Medical is dedicated to advancing healthcare through cutting-edge innovation with a patient-centric approach.
About Sanford Health
Sanford Health, the largest rural health system in the United States, is dedicated to transforming the health care experience and providing access to world-class health care in America’s heartland. Headquartered in Sioux Falls, South Dakota, the organization serves 1.4 million patients and nearly 200,000 health plan members across 250,000 square miles. The integrated health system has 45 hospitals, 211 clinic locations, more than 160 Good Samaritan Society senior living centers, 2,900 Sanford physicians and advanced practice providers, 540 active clinical trials, and nine world clinic locations around the globe. Learn more about Sanford Health’s commitment to shaping the future of rural health care across the lifespan at sanfordhealth.org or Sanford Health News.
###
